title: Serum levels of soluble Fas, nitric oxide and cytokines in acute decompensated cirrhotic patients.
abstract: OBJECTIVE
  To evaluate plasma levels of nitrite/nitrate (NOx), soluble Fas (sFas) antigen, tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6) in patients with compensated and acute decompensated cirrhosis and to evaluate mediators causing acute decompensation in liver cirrhosis.
  
  
  METHODS
  This prospective study was conducted in the medical intensive care unit of an academic tertiary center. Fifty-five patients with acute decompensation (gastrointestinal hemorrhage, encephalopathy, hydropic decompensation) and twenty-five patients with compensated liver cirrhosis were included. Blood samples were taken for analyses of sFas, Nox, IL-6, TNF-alpha. Liver enzymes and kidney functions were also tested.
  
  
  RESULTS
  In patients with acute decompensation, plasma sFas levels were higher than in non-decompensated patients (15305 +/- 4646 vs 12458 +/- 4322 pg/mL, P < 0.05). This was also true for the subgroup of patients with alcoholic liver cirrhosis (P < 0.05). The other mediators were not different and none of the parameters predicted survival, except for ALT (alanine-aminotransferase). In patients with portal-hypertension-induced acute hemorrhage, NOx levels were significantly lower than in patients with other forms of decompensation (70.8 +/- 48.3 vs 112.9 +/- 74.9 pg/mL, P < 0.05). When NOx levels were normalized to creatinine levels, the difference disappeared. IL-6, TNF-alpha and sFas were not different between bleeders and non-bleeders. In decompensated patients sFas, IL-6 and NOx levels correlated positively with creatinine levels, while IL-6 levels were dependent on Child class.
  
  
  CONCLUSIONS
  In acute decompensated cirrhotic patients sFas is increased, suggesting a role of apoptosis in this process and patients with acute bleeding have lower NOx levels. However, in this acute complex clinical situation, kidney function seems to have a predominant influence on mediator levels.
authors.affiliation: Gastroenterology, Department of Medicine, St. Elisabeth-Hospital, PO Box 580, Dorsten 46225, Germany. c.elsing@krankenhaus-dorsten.de
authors.forename: Christoph
authors.initials: C
authors.lastname: Elsing
authors.forename: Sabine
authors.initials: S
authors.lastname: Harenberg
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Stremmel
authors.forename: Thomas
authors.initials: T
authors.lastname: Herrmann
mesh_terms: D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D003404:Creatinine / Q000097:blood; D016207:Cytokines / Q000097:blood*; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000097:blood* / Q000209:etiology; D006801:Humans; D006975:Hypertension, Portal / Q000097:blood / Q000150:complications; D015850:Interleukin-6 / Q000097:blood; D008103:Liver Cirrhosis / Q000097:blood* / Q000150:complications / Q000401:mortality; D008297:Male; D008875:Middle Aged; D009569:Nitric Oxide / Q000097:blood*; D014409:Tumor Necrosis Factor-alpha / Q000097:blood; D019014:fas Receptor / Q000097:blood*
chemical_list: D016207:Cytokines; D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D019014:fas Receptor; D009569:Nitric Oxide; D003404:Creatinine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase